Tinavi Medical Technologies Co.,Ltd. (SHA:688277)
China
· Delayed Price · Currency is CNY 19.09
-0.77 (-3.88%)
Apr 29, 2026, 3:00 PM CST
SHA:688277 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -196.11 | -121.13 | -156.39 | -110.58 | -79.93 | Upgrade
|
| Depreciation & Amortization | 44.85 | 37.2 | 40.61 | 44.51 | 35.31 | Upgrade
|
| Other Amortization | 4.25 | 5.79 | 4.11 | 5.65 | 6.3 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0 | -5.64 | -0 | 0.01 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | -0.23 | 0.26 | 0.03 | 0.74 | 0.42 | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.73 | -40.4 | -56.22 | -0.1 | -3.57 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 4.58 | 1.38 | -2.53 | 5.77 | Upgrade
|
| Other Operating Activities | 16.24 | 11.14 | 6.03 | 2.19 | 0.63 | Upgrade
|
| Change in Accounts Receivable | 8.62 | -5.25 | -86.69 | -2.44 | -25.02 | Upgrade
|
| Change in Inventory | -16.45 | -5.56 | 14.07 | -6.1 | -3.31 | Upgrade
|
| Change in Accounts Payable | -19.75 | -33.06 | 26.92 | 11.97 | 20.18 | Upgrade
|
| Change in Other Net Operating Assets | 68.73 | 31.84 | 25.13 | 1 | -12.55 | Upgrade
|
| Operating Cash Flow | -51.17 | -98.65 | -170.5 | -87.51 | -77.76 | Upgrade
|
| Capital Expenditures | -29.71 | -36.69 | -221.03 | -59.59 | -238.66 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.11 | 0.01 | - | - | Upgrade
|
| Divestitures | - | 52 | 11.81 | - | - | Upgrade
|
| Investment in Securities | -45.5 | 59.61 | -49.51 | 66.48 | 127.73 | Upgrade
|
| Other Investing Activities | 0.52 | 0.71 | 0.55 | 2.73 | 12.2 | Upgrade
|
| Investing Cash Flow | -74.7 | 75.74 | -258.17 | 9.62 | -98.73 | Upgrade
|
| Long-Term Debt Issued | 58.43 | 62.01 | 201.17 | 25 | - | Upgrade
|
| Long-Term Debt Repaid | -60.94 | -83.9 | -27.94 | -22.94 | -28.91 | Upgrade
|
| Net Debt Issued (Repaid) | -2.51 | -21.89 | 173.23 | 2.06 | -28.91 | Upgrade
|
| Issuance of Common Stock | 59.06 | 29.8 | 363.7 | - | 7.02 | Upgrade
|
| Common Dividends Paid | -7.18 | -9.06 | -4.68 | -0.76 | - | Upgrade
|
| Other Financing Activities | 55 | -0.64 | -3.94 | - | 17.08 | Upgrade
|
| Financing Cash Flow | 104.37 | -1.79 | 528.3 | 1.3 | -4.8 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.94 | 0.64 | -0.17 | 0.65 | - | Upgrade
|
| Net Cash Flow | -22.43 | -24.06 | 99.47 | -75.93 | -181.29 | Upgrade
|
| Free Cash Flow | -80.88 | -135.34 | -391.53 | -147.1 | -316.42 | Upgrade
|
| Free Cash Flow Margin | -29.01% | -75.68% | -186.41% | -94.18% | -202.80% | Upgrade
|
| Free Cash Flow Per Share | -0.18 | -0.30 | -0.88 | -0.35 | -0.75 | Upgrade
|
| Cash Income Tax Paid | 4.75 | 5.54 | -4.3 | -4.85 | 2.71 | Upgrade
|
| Levered Free Cash Flow | -14.39 | -116.7 | -307.34 | -111.36 | -315.47 | Upgrade
|
| Unlevered Free Cash Flow | -14.39 | -110.98 | -303.32 | -108.89 | -313.38 | Upgrade
|
| Change in Working Capital | 82.57 | 9.54 | -10.06 | -27.39 | -42.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.